{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:53:31Z","timestamp":1793832811348,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrc.2026.153709","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:54:47Z","timestamp":1775098487000},"page":"153709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Saikosaponin D inhibits bladder cancer growth and enhances the synergistic antitumor effect of gemcitabine by targeting PI3K\/AKT-mediated ferroptosis"],"prefix":"10.1016","volume":"816","author":[{"given":"Hai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6310-8380","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrc.2026.153709_bib1","doi-asserted-by":"crossref","first-page":"7655","DOI":"10.1038\/s41598-025-92033-5","article-title":"Trends in the global, regional, and national burden of bladder cancer from 1990 to 2021: an observational study from the global burden of disease study 2021","volume":"15","author":"Su","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153709_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153709_bib3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur. Urol. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153709_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12967-025-06138-6","article-title":"Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153709_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","article-title":"NCCN guidelines\u00ae insights: bladder cancer, version 3.2024","volume":"22","author":"Flaig","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw. : J. Natl. Compr. Cancer Netw."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153709_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31587","article-title":"Bibliometric insights into drug resistance in bladder cancer: two decades of progress (1999-2022)","volume":"10","author":"Huang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2026.153709_bib7","article-title":"Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect","volume":"129","author":"Han","year":"2020","journal-title":"Biomed. Pharmacotherapy = Biomedecine Pharmacotherapie"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153709_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.eururo.2021.01.032","article-title":"Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes","volume":"79","author":"Catto","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbrc.2026.153709_bib9","article-title":"Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion","volume":"16","author":"Huang","year":"2025","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.bbrc.2026.153709_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113206","article-title":"Biomarkers of bladder cancer: cell-free DNA, epigenetic modifications and non-coding RNAs","volume":"23","author":"Harsanyi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153709_bib11","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/s12935-020-01660-7","article-title":"Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K\/Akt\/mTOR pathway: go four better to treat bladder cancer","volume":"20","author":"Khan","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153709_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13046-022-02377-3","article-title":"TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K\/AKT pathway in bladder cancer","volume":"41","author":"Chi","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153709_bib13","article-title":"G3BP1 and SLU7 jointly promote immune evasion by downregulating MHC-I via PI3K\/Akt activation in bladder cancer","volume":"11","author":"Zheng","year":"2024","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"6","key":"10.1016\/j.bbrc.2026.153709_bib14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4111\/icu.20240250","article-title":"Dasatinib induces apoptosis and autophagy by suppressing the PI3K\/Akt\/mTOR pathway in bladder cancer cells","volume":"65","author":"Ho","year":"2024","journal-title":"Investig. Clin. Urol."},{"key":"10.1016\/j.bbrc.2026.153709_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1372330","article-title":"Regulation of ferroptosis by PI3K\/Akt signaling pathway: a promising therapeutic axis in cancer","volume":"12","author":"Su","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153709_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-024-02213-6","article-title":"Tailoring traditional Chinese medicine in cancer therapy","volume":"24","author":"Li","year":"2025","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153709_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/jox12040027","article-title":"Chemotherapeutic potential of saikosaponin D: experimental evidence","volume":"12","author":"Manoharan","year":"2022","journal-title":"J. Xenobiotics"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153709_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s43440-024-00569-6","article-title":"Advances in the anti-tumor mechanisms of saikosaponin D","volume":"76","author":"Jia","year":"2024","journal-title":"Pharmacol. Rep. : PR"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153709_bib19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1248\/bpb.b21-01025","article-title":"Saikosaponin A inhibits growth of human bladder carcinoma T24 and 5637 cells both in vitro and in vivo","volume":"45","author":"Zhou","year":"2022","journal-title":"Biol. Pharmaceut. Bull."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153709_bib20","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1007\/s00210-024-03676-6","article-title":"Saikosaponin D suppresses esophageal squamous cell carcinoma via the PI3K-AKT signaling pathway","volume":"398","author":"Duan","year":"2025","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153709_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71184","article-title":"The role of TAp63\u03b3 and P53 point mutations in regulating DNA repair, mutational susceptibility and invasion of bladder cancer cells","volume":"10","author":"Wang","year":"2021","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153709_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.153709_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1043283","article-title":"Ferroptosis: a new therapeutic target for bladder cancer","volume":"13","author":"Zeng","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153709_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.832892","article-title":"Ferroptosis patterns and tumor microenvironment infiltration characterization in bladder cancer","volume":"10","author":"Xia","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"21","key":"10.1016\/j.bbrc.2026.153709_bib25","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbrc.2026.153709_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/febs.70068","article-title":"The N6-methyladenosine reader IGF2BP3 promotes bladder cancer progression through enhancing HSP90AB1 expression","author":"Chen","year":"2025","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153709_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060802","article-title":"The translational regulation in mTOR pathway","volume":"12","author":"Yang","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153709_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s43556-024-00176-0","article-title":"Understanding PI3K\/Akt\/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example","volume":"5","author":"Zheng","year":"2024","journal-title":"Mol. Biomed."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153709_bib29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41598-023-50476-8","article-title":"Hesperetin promotes bladder cancer cells death via the PI3K\/AKT pathway by network pharmacology and molecular docking","volume":"14","author":"Lv","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153709_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155220","article-title":"Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT\/GSK3\u03b2\/NRF2\/GPX4 axis","volume":"123","author":"Huang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2026.153709_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156789","article-title":"Mori folium ethanol extracts induce ferroptosis and suppress gastric cancer progression by inhibiting the AKT\/GSK3\u03b2\/NRF2 axis","volume":"142","author":"Hu","year":"2025","journal-title":"Phytomedicine : Int. J. Phytothe. Phytopharmacol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153709_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s12935-021-02264-5","article-title":"Roles of ferroptosis in urologic malignancies","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153709_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ph15101199","article-title":"Berberine overcomes gemcitabine-associated chemoresistance through regulation of Rap1\/PI3K-Akt signaling in pancreatic ductal adenocarcinoma","volume":"15","author":"Okuno","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153709_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/genes13030466","article-title":"Recent development of prodrugs of gemcitabine","volume":"13","author":"Pandit","year":"2022","journal-title":"Genes"},{"issue":"20","key":"10.1016\/j.bbrc.2026.153709_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010944","article-title":"Ferroptosis: at the crossroad of gemcitabine resistance and tumorigenesis in pancreatic cancer","volume":"22","author":"Yang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153709_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00018-023-04907-4","article-title":"Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance","volume":"80","author":"Ren","year":"2023","journal-title":"Cell. Mol. Life Sci. : CMLS"},{"key":"10.1016\/j.bbrc.2026.153709_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111337","article-title":"The MEF2A\/SNHG16\/miR-425-5p\/NOTCH2 axis induces gemcitabine resistance by inhibiting ferroptosis in the starving bladder tumor microenvironment","volume":"122","author":"Zhou","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2026.153709_bib38","article-title":"Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.153709_bib39","article-title":"Single-cell RNA-Seq reveals the promoting role of ferroptosis tendency during lung adenocarcinoma EMT progression","volume":"9","author":"Yao","year":"2021","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:17:56Z","timestamp":1778653076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26004730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"alternative-id":["S0006291X26004730"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153709","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saikosaponin D inhibits bladder cancer growth and enhances the synergistic antitumor effect of gemcitabine by targeting PI3K\/AKT-mediated ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153709"}}